David Hirsch, Director at Poseida Therapeutics, Inc. (PSTX), bought 2,714,245 shares at $16.00 ($4.0M) on 2020-07-14, disclosed to the SEC on 2020-07-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,464,245 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $1.47 avg | 2,714,245 | $4.0M | 100% |
| Filing → |
| COLL | SELL | 2019-09-03 | $515K | — | Filing → |
| MTEM | BUY | 2018-09-25 | $2.0M | — | Filing → |
| TCDA | BUY | 2018-07-02 | $2.5M | — | Filing → |